A detailed history of Allstate Investment Management CO transactions in Charles River Laboratories International, Inc. stock. As of the latest transaction made, Allstate Investment Management CO holds 1,246 shares of CRL stock, worth $231,955. This represents 0.01% of its overall portfolio holdings.

Number of Shares
1,246
Holding current value
$231,955
% of portfolio
0.01%

Shares

1 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2022

Feb 14, 2023

BUY
$197.11 - $250.07 $245,599 - $311,587
1,246 New
1,246 $0

Others Institutions Holding CRL

About CHARLES RIVER LABORATORIES INTERNATIONAL, INC.


  • Ticker CRL
  • Exchange NYSE
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 50,863,300
  • Market Cap $9.47B
  • Description
  • Charles River Laboratories International, Inc., a non-clinical contract research organization, provides drug discovery, non-clinical development, and safety testing services in the United States, Europe, Canada, the Asia Pacific, and internationally. It operates through three segments: Research Models and Services (RMS), Discovery and Safety Ass...
More about CRL
Track This Portfolio

Track Allstate Investment Management CO Portfolio

Follow Allstate Investment Management CO and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Allstate Investment Management CO, based on Form 13F filings with the SEC.

News

Stay updated on Allstate Investment Management CO with notifications on news.